Poor adherence to medications remains a major challenge in the treatment of osteoporosis (OP). Medication non-adherence is associated with increased risk of fractures, leading to a substantial decrease in the clinical and economic benefits of drug therapy. It is therefore extremely important to identify potential solutions to manage patient's adherence to therapy. A working group was therefore convened by IOF and ESCEO to review determinants and potential adherence-management interventions, and to make recommendations for medical practice and for further research. A systematic review and a face-to-face meeting in Geneva in January 2019 (including 21 experts) were conducted. During this IOF-ESCEO symposium, three presentations will be made to highlight the findings and recommendations of the working group, and more specifically, (1) to review the determinants of non-adherence to (OP) medications, (2) to provide recommendations for practice how to manage OP medication adherence and (3) to make recommendations for further research. These recommendations are intended for clinicians to manage adherence of their patients, and to researchers and policy makers to design, facilitate and appropriately use adherence-management interventions.
